Jukka Kalervo Karjalainen
Chief Operating Officer chez Neurotez, Inc.
Profil
Jukka Kalervo Karjalainen is currently the Chief Operating Officer at Neurotez, Inc. He previously worked as the Medical Director at Eli Lilly Finland Oy AB from 1998 to 2002, as well as held positions as VP & Director-Medical & Regulatory Affairs at Biovail Pharmaceuticals Canada, Chief Operating & Medical Officer at Bradmer Pharmaceuticals, Inc., and Chief Medical Officer at Clarmin Explorations, Inc. He also served as the Chief Medical Officer at Cybin, Inc. from 2019 to 2021.
Postes actifs de Jukka Kalervo Karjalainen
| Sociétés | Poste | Début |
|---|---|---|
Neurotez, Inc.
 Neurotez, Inc. BiotechnologyHealth Technology Neurotez, Inc. opertaes as a corporation, which develops leptin product as a novel hormone replacement therapy for alzheimer’s disease. The company was founded by Nikolaos Tezapsidis in 2004 and is headquartered in Bridgewater, NJ. | Chief Operating Officer | - |
Anciens postes connus de Jukka Kalervo Karjalainen
| Sociétés | Poste | Fin |
|---|---|---|
| CYBIN INC. | Chief Tech/Sci/R&D Officer | 01/02/2021 |
| Eli Lilly Finland Oy AB | Chief Tech/Sci/R&D Officer | 01/07/2002 |
Biovail Pharmaceuticals Canada
 Biovail Pharmaceuticals Canada Medical DistributorsDistribution Services Biovail Pharmaceuticals Canada sells pharmaceutical products. The private company is based in Mississauga, Canada. | Chief Tech/Sci/R&D Officer | - |
Bradmer Pharmaceuticals, Inc.
 Bradmer Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bradmer Pharmaceuticals, Inc. engaged in the development and commercialization of cancer therapies. The company was founded on June 16, 2005 and wass headquartered in Toronto, Canada. | Chief Operating Officer | - |
| CLARMIN EXPLORATIONS INC. | Chief Tech/Sci/R&D Officer | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CYBIN INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Bradmer Pharmaceuticals, Inc.
Bradmer Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bradmer Pharmaceuticals, Inc. engaged in the development and commercialization of cancer therapies. The company was founded on June 16, 2005 and wass headquartered in Toronto, Canada. | Commercial Services |
| Eli Lilly Finland Oy AB | |
Neurotez, Inc.
Neurotez, Inc. BiotechnologyHealth Technology Neurotez, Inc. opertaes as a corporation, which develops leptin product as a novel hormone replacement therapy for alzheimer’s disease. The company was founded by Nikolaos Tezapsidis in 2004 and is headquartered in Bridgewater, NJ. | Health Technology |
Biovail Pharmaceuticals Canada
Biovail Pharmaceuticals Canada Medical DistributorsDistribution Services Biovail Pharmaceuticals Canada sells pharmaceutical products. The private company is based in Mississauga, Canada. | Distribution Services |
Clarmin Explorations, Inc.
 Clarmin Explorations, Inc. Precious MetalsNon-Energy Minerals Clarmin Explorations, Inc. is an exploration company. The firm engages in the exploration and development of mineral properties. It holds interest in the Arlington property. The company was founded on October 13, 2016 and is headquartered in Toronto, Canada. | Non-Energy Minerals |
